RTW vs. TPVE, YOLO, FFWD, PMGR, JTWO, VEN2, KZG, FIPP, EMVC, and LMS
Should you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Triple Point Income VCT Plc E (TPVE), Yolo Leisure and Technology (YOLO), Fastforward Innovations (FFWD), Premier Miton Glb Renewables Trust (PMGR), J2 Acquisition (JTWO), Ventus 2 VCT (VEN2), Kazera Global (KZG), Frontier IP Group (FIPP), EMV Capital (EMVC), and LMS Capital (LMS). These companies are all part of the "asset management" industry.
RTW Biotech Opportunities vs.
RTW Biotech Opportunities (LON:RTW) and Triple Point Income VCT Plc E (LON:TPVE) are both small-cap financial services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, community ranking, risk, earnings, profitability, analyst recommendations and valuation.
RTW Biotech Opportunities has higher earnings, but lower revenue than Triple Point Income VCT Plc E. Triple Point Income VCT Plc E is trading at a lower price-to-earnings ratio than RTW Biotech Opportunities, indicating that it is currently the more affordable of the two stocks.
3.9% of RTW Biotech Opportunities shares are held by institutional investors. 16.2% of RTW Biotech Opportunities shares are held by insiders. Comparatively, 54.3% of Triple Point Income VCT Plc E shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
RTW Biotech Opportunities received 1 more outperform votes than Triple Point Income VCT Plc E when rated by MarketBeat users.
RTW Biotech Opportunities has a net margin of 1,994.76% compared to Triple Point Income VCT Plc E's net margin of 32.42%. RTW Biotech Opportunities' return on equity of 21.42% beat Triple Point Income VCT Plc E's return on equity.
In the previous week, RTW Biotech Opportunities had 1 more articles in the media than Triple Point Income VCT Plc E. MarketBeat recorded 1 mentions for RTW Biotech Opportunities and 0 mentions for Triple Point Income VCT Plc E. RTW Biotech Opportunities' average media sentiment score of 0.33 beat Triple Point Income VCT Plc E's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the media.
RTW Biotech Opportunities has a beta of 0.6, indicating that its stock price is 40% less volatile than the S&P 500. Comparatively, Triple Point Income VCT Plc E has a beta of 0.14, indicating that its stock price is 86% less volatile than the S&P 500.
Summary
RTW Biotech Opportunities beats Triple Point Income VCT Plc E on 9 of the 13 factors compared between the two stocks.
Get RTW Biotech Opportunities News Delivered to You Automatically
Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
RTW Biotech Opportunities Competitors List
Related Companies and Tools
This page (LON:RTW) was last updated on 1/13/2025 by MarketBeat.com Staff
